Immunosuppressants API Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The global immunosuppressants API market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The global immunosuppressants API Market is expected to grow rapidly during the forecast period mainly due to the continuous technological advances in tissue engineering. Additionally, an increase in the incidence of autoimmune disorders such as multiple sclerosis, alopecia areata, and arthritis has a positive impact on market growth.

The increase in number of organ transplants such as liver and kidney transplants worldwide is expected to boost market growth over the next few years. However, certain factors that could serve as major obstacles to the growth of the global immunosuppressants API Market in the coming years include the high costs associated with the API and the lack of availability of organ donors. The autoimmune disease segment held the largest market share and is forecast to drive the market growth.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Method
  • By Application
  • By Type
  • By Product
  • By APIs
  • End-user
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Biocon Ltd., Concord Biotech Ltd., Pfizer Inc., RPG Life Science Ltd., and Zhejiang Hisun Pharmaceutical Co. Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Immunosuppressants API Market Report by Segment

By Method

• Synthetic chemistry
• Peptide Chemistry
• Fermentation
• Chromatographic Purification

By Application

• Autoimmune Disease
• Organ Transplant

By Type

• Corticosteroids
• Janus Kinase Inhibitor
• Calcineurin Inhibitors
• mTOR Inhibitor
• Others

By Product

• Tablets
• Capsules
• Liquids
• Injections

By APIs

• Tacrolimus
• Sirolimus
• Everolimus
• Mycophenolate Mofetil
• Mycophenolate Sodium

By End-User

• Biotechnology & Biopharmaceutical Co.
• CMOs
• CROs
• CDMOs
• Other